News & Updates

Show Multimedia Only
HDP exposure in gestation, maternal hypertension spell increased hypertension risk in offspring

HDP exposure in gestation, maternal hypertension spell increased hypertension risk in offspring

03 Aug 2023

Exposure to hypertensive disorders of pregnancy (HDP) in gestation and maternal hypertension both contribute to an elevated risk of chronic hypertension in offspring, as reported in a study.

HDP exposure in gestation, maternal hypertension spell increased hypertension risk in offspring

03 Aug 2023
Hybrid, bismuth quadruple therapies superior to high-dose dual therapy for H pylori eradication

Hybrid, bismuth quadruple therapies superior to high-dose dual therapy for H pylori eradication

03 Aug 2023

In the first-line treatment of Helicobacter pylori (H pylori) infection, 14-day hybrid therapy and 10-day bismuth quadruple therapy demonstrate superiority over 14-day high-dose dual therapy, reports a Taiwan study. However, high-dose therapy results in fewer adverse events than hybrid bismuth quadruple therapies.

Hybrid, bismuth quadruple therapies superior to high-dose dual therapy for H pylori eradication

03 Aug 2023
Synbiotics help reduce weight in adults with overweight, obesity

Synbiotics help reduce weight in adults with overweight, obesity

03 Aug 2023
Abrocitinib effectively controls AD regardless of dosing regimen

Abrocitinib effectively controls AD regardless of dosing regimen

03 Aug 2023 byAudrey Abella

In patients with moderate-to-severe atopic dermatitis (AD), flexible dosing of abrocitinib, an oral, once-daily Janus kinase 1-selective inhibitor, appeared as beneficial as the continuous high-dose regimen. This was demonstrated in a post hoc analysis of two studies from the JADE* clinical development programme.

Abrocitinib effectively controls AD regardless of dosing regimen

03 Aug 2023
Awareness is key to preventing lipohypertrophy in diabetic patients on insulin

Awareness is key to preventing lipohypertrophy in diabetic patients on insulin

03 Aug 2023